Created in 2012, the MII program was created as part of a partnership between the State of Maryland and five Maryland university research institutes: Johns Hopkins University; Morgan State University; University of Maryland, Baltimore; University of Maryland, Baltimore County; and University of Maryland, College Park. The mission of the program is to accelerate the commercialization of promising technologies with significant commercial potential while leveraging the strengths of each partner university.

“The past year has seen a record number of applications in various industrial sectors for new innovative technologies,” said Dr. Arti Santhanam, executive director of the MII. “We are always on the lookout for new opportunities and are committed to continuing to grow our portfolio companies and take their technologies to the next level. “

The invested fund $ 150,000 each in the following 12 companies through the company training phase of the program:

  • BLOCKsyncop, situated in Mountains, is a Johns Hopkins University spinout, developing a monitoring device that provides an objective measurement to quantify the controlled delivery and effectiveness of neuronal blocks on pain.
  • Capsulomics, situated in Baltimore, is a Johns Hopkins University spin-out, resolving diagnostic and prognostic uncertainties to help prevent, detect and treat gastrointestinal diseases.
  • Empower therapy, situated in Baltimore, is a University of Maryland, Baltimore spinout, a digital therapy company that uses functional targeting for the non-invasive neuromodulation of pain sensitivity.
  • Evincis Bio, located at Baltimore, is a Johns Hopkins University spin-out, solving therapeutic challenges in urology with innovative medical technologies.
  • Geminus Therapeutics, located at Baltimore, is a University of Maryland, Baltimore spin-out, developing the best artemisinin (ART714) for the treatment of leukemia.
  • Geothermal technologies, situated in beautiful air, is a Johns Hopkins University spin-out, developing technology to provide clean and economically competitive energy.
  • Haystack Solutions, situated in College Park, is a University of Maryland, College Park spinout developing a revolutionary assessment to identify cybersecurity talent and optimize human capital.
  • Cryotherapy Kubanda, situated in Baltimore, is a Johns Hopkins University spinout, providing affordable cancer care for pets with a new low-cost cryoablation device.
  • ML4Cyber, situated in Baltimore, is a University of Maryland, Baltimore County spin-out developing cybersecurity solutions for machine learning.
  • Square meadow, situated in Cockeysville, is a University of Maryland, Baltimore County spin-out that builds products to help healthcare organizations prioritize patient care based on risk levels.
  • Silvec Biologics, situated in Rockville, is a University of Maryland, College Park spin-out, producing a commercial solution to alleviate deadly citrus diseases.
  • Synteris, situated in Rockville, is a Johns Hopkins University spinout, developing first-rate precursor powders for 3D printing of high temperature ceramics.

A full list of funded companies can be found on the IRM website. Visit the TEDCO YouTube channel to view a video of IBD highlights: https://youtu.be/2rxq9EcjQNQ.

The program also funded a total of 36 FY21 grants for its technology assessment projects. These projects reflect technological excellence and the diversity of our Maryland partner universities, including:

  • Of Johns Hopkins University, developing cryptoplasmic transfer cell therapy (CTC) for retinitis pigmentosa
  • Of University of Maryland, College Park, development of capacitive touch cuffs to track hand and finger gestures
  • Of University of Maryland, Baltimore County, creating safe and flexible Zn (RZB) rechargeable alkaline batteries

A full list of fellows can be found on the website IRM website.

As startups join TEDCO’s MII portfolio, they also gain access to a range of TEDCO resources, from CEO mentors and roundtables to loaned executives. These companies receive the help and support they need throughout team building, balancing funding elements and negotiating deals.

“Over the past nine years, the program has shown the impact it can have on from Maryland entrepreneurial community, ”said Robert hallenbeck, Chairman of the MII Board of Directors. “MII’s latest funding round is a great example of the innovation we have in the state and we are committed to helping these companies through the next stages of development.”

In the nine years since its launch, the IRM has disbursed $ 43 million, reduced the risks of 276 unique technologies and created 119 start-ups. MII’s start-up portfolio continued to grow $ 571.5 million in follow-up funding and has resulted in seven exits to date. In addition to being an essential part of the Maryland start-up ecosystem, these companies have created economic value by creating full-time jobs for highly skilled technology workers with an average salary of $ 100,000.

“For nearly a decade, MII has supported the commercialization of innovative research from from Maryland world-class universities, ”said Renee winsky, CEO of Leadership Maryland. “We, the members of the IRM Board of Directors, are all grateful to play a role in the management of this remarkable program. ”

To view the MII 2021 Annual Report, please visit Click here.

For more details on eligibility and application requirements, please visit www.tedcomd.com/MII.

About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances the growth of economic empowerment by fostering an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests and helps grow technology and life science based businesses in Maryland. Learn more about www.tedcomd.com.

Media contact
Tammi thomas
Marketing and Communication Director, TEDCO
[email protected]

SOURCE TEDCO